Data Snapshot: Sep 06, 2026
$100K+

Aug-2026

Sales

Growth

Trend

6-Month

26

Product Count

SKUs

$26.87

Avg Price

46.8%

YoY Sales Change

-11.2%

YoY Price Change

Beneleaves

Where to Buy

Beneleaves is stocked at 97 licensed dispensaries across Ohio, with the deepest coverage in Columbus, Cincinnati, Cleveland, Dayton, and Lorain. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/11915.json?v=20260905
Beneleaves Sales

Market Insights Snapshot

Beneleaves Historical Sales by Category

In August 2026, Beneleaves concentrated 91.44% of sales in Capsules, where year-over-year growth reached 66.45% even as month-over-month volume slipped 7.24%; alongside this, Topical held a 7.19% share with a 5.35% year-over-year decline but a 21.33% month-over-month rebound. Smaller lines contracted sharply: Edible fell 63.71% year-over-year and 69.21% month-over-month to 0.89% share, while Vapor Pens declined 84.55% year-over-year and 71.65% month-over-month to 0.48% share. With brand-level sales up 46.81% year-over-year despite an 11.16% decline in average price to $26.87, the pattern implies that Capsules-led volume gains are carrying growth while non-core formats are being deprioritized in the mix.

The mix shift positions Beneleaves as a Capsules specialist: a 1st-place rank in Capsules in Ohio pairs with a 66.45% year-over-year surge in that category, contrasting with a 5.35% year-over-year decline in Topical and an 84.55% year-over-year slide in Vapor Pens. The 21.33% month-over-month recovery in Topical alongside a 7.24% month-over-month dip in Capsules suggests tactical elasticity between two adjacent need-states, while the 69.21% and 71.65% month-over-month drops in Edible and Vapor Pens indicate deliberate pruning rather than seasonal volatility. This implies a defensible positioning concentrated in Capsules with selective experimentation in Topical, trading price (−11.16% year-over-year) for share capture and rank stability in the core format.

Aug-2026 Rank
Capsules
Topical
1
5
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
91.4%
$26.64
+66.5%
-7.2%
Topical
7.2%
$31.67
-5.4%
+21.3%
Edible
0.9%
$18.64
-63.7%
-69.2%
Vapor Pens
0.5%
$32.04
-84.5%
-71.7%
Beneleaves

Competitive Landscape

Beneleaves is ranked #1 in OH Capsules in August 2026, unchanged from #1 a year earlier, and it has held #1 for the past three months; this stability contrasts with Main Street Health holding at #2 while posting a -2.7% year-over-year sales decline and UB GOOD climbing from #4 to #3 on 23.6% YoY growth as Butterfly Effect - Grow Ohio slipped from #3 to #4 with a -26.6% YoY drop; the combination of zero rank movement at the top and diverging competitor trajectories implies Beneleaves’ position is anchored by retention rather than acceleration, signaling that future risk comes from fast risers like UB GOOD rather than from legacy peers losing share.

Beneleaves market ranking for OH Capsules

Beneleaves

Notable Products

The steepest decline came from Hybrid RSO Capsules 11-Pack (550mg), down 28.6% month over month while sitting at rank 5, as RSO Capsules 11-Pack (330mg) also fell 26.9% at rank 7, indicating price-sensitive RSO formats lost traction despite the flagship RSO Capsules 22-Pack (660mg) holding rank 1 with a 10.2% drop. In contrast, Hybrid Unflavored RSO Capsules 11-Pack (110mg) jumped 42.9% at rank 6 and CBN/THC 1:1 Hypnos + CBN Capsules 22-Pack (220mg CBN, 220mg THC) rose 21.6% at rank 8, while Indica Hypnos Capsules 11-Pack (440mg) inched up 4.9% at rank 4. Eight of the top ten are Capsules, and this concentration alongside a Topical at rank 10 up 9.7% with $11,868 in August 2026 sales points to diversification at the edge of a capsules-dominant lineup. The pattern implies Beneleaves is pivoting toward lower-dose or function-led capsules while premium-dose RSO variants face elasticity pressure, setting a need to rebalance pack sizes and cannabinoids within the Capsules-heavy mix.

Product
Category
Apr-2026
May-2026
Jun-2026
Jul-2026
Aug-2026
MoM %
RSO Capsules 22-Pack (660mg)
Capsules
1
1
1
1
1
-10.2%
Sativa Helios Capsules 11-Pack (440mg)
Capsules
3
3
3
3
2
-2.1%
CBD/THC/CBG/CBC/CBN Entourage Effect Capsules 22-Pack (110mg CBD, 220mg THC, 339mg CBG, 321mg CBN, 303mg CBC)
Capsules
2
2
2
2
3
-21.8%
Indica Hypnos Capsules 11-Pack (440mg)
Capsules
4
4
5
6
4
+4.9%
Hybrid RSO Capsules 11-Pack (550mg)
Capsules
>10
>10
7
4
5
-28.6%
Hybrid Unflavored RSO Capsules 11-Pack (110mg)
Capsules
7
7
10
8
6
+42.9%
RSO Capsules 11-Pack (330mg)
Capsules
>10
8
6
5
7
-26.9%
CBN/THC 1:1 Hypnos + CBN Capsules 22-Pack (220mg CBN, 220mg THC)
Capsules
5
6
8
9
8
+21.6%
THC/CBG 1:1 Sativa Helios Capsules 22-Pack (220mg THC, 220mg CBG)
Capsules
6
5
4
7
9
-4.2%
CBG/THC 1:1 Hypnos Wintergreen Lotion (295mg CBG, 295mg THC, 3oz)
Topical
8
9
9
10
10
+9.7%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market